Holen Sie sich die Stockscreener-App
26.56
0.73%
0.16
Finanzdaten der Celldex Therapeutics Inc-Aktie (CLDX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
96.22%
0.156
|
4.131 | 1.517 | 0.268 | 0.967 |
Operating Expenses
|
20.78%
40.76
|
51.46 | 42.76 | 33.47 | 33.44 |
| Benefits Costs and Expenses |
5.48%
40.76
|
38.65 | 42.76 | 33.47 | 33.44 |
| Costs And Expenses |
21.24%
40.76
|
51.76 | 42.76 | 33.47 | 33.44 |
| Operating Income/Loss |
14.74%
-40.61
|
-47.63 | -41.24 | -33.20 | -32.47 |
| Income/Loss From Continuing Operations Before Tax |
17.66%
-40.61
|
-34.51 | -41.24 | -30.50 | -29.36 |
| Income/Loss From Continuing Operations After Tax |
353.21%
-32.81
|
-7.239 | -38.26 | -30.50 | -29.36 |
|
Net Income/Loss
|
24.24%
-32.81
|
-43.31 | -38.26 | -30.50 | -29.36 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
4,782%
0.0589
|
0.00121 | 0.0473 | 0.0473 | 0.0472 |
| Diluted Average Shares |
4,782%
0.0589
|
0.00121 | 0.0473 | 0.0473 | 0.0472 |
| Basic Earnings Per Share |
33.33%
-0.56
|
-0.84 | -0.81 | -0.65 | -0.62 |
| Diluted Earnings Per Share |
33.33%
-0.56
|
-0.84 | -0.81 | -0.65 | -0.62 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):